Chemoinformaics analysis of 2,6-Dimethoxy-3-methyl-9H-carbazole
| Molecular Weight | 241.29 | nRot | 2 |
| Heavy Atom Molecular Weight | 226.17 | nRig | 16 |
| Exact Molecular Weight | 241.11 | nRing | 3 |
| Solubility: LogS | -5.1 | nHRing | 1 |
| Solubility: LogP | 8.999 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 15 |
| nHA | 2 | APOL | 37.7559 |
| nHD | 1 | BPOL | 19.0901 |
| QED | 0.108 |
| Synth | 4.372 |
| Natural Product Likeliness | 1.365 |
| NR-PPAR-gamma | 0.986 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.003 |
| HIA | 0.008 |
| CACO-2 | -5.141 |
| MDCK | 0.0000142 |
| BBB | 0.005 |
| PPB | 0.954711 |
| VDSS | 1.306 |
| FU | 0.0126372 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.326 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.044 |
| CYP2c9-sub | 0.949 |
| CYP2d6-inh | 0.032 |
| CYP2d6-sub | 0.763 |
| CYP3a4-inh | 0.193 |
| CYP3a4-sub | 0.032 |
| CL | 7.238 |
| T12 | 0.076 |
| hERG | 0.04 |
| Ames | 0.027 |
| ROA | 0.307 |
| SkinSen | 0.954 |
| Carcinogencity | 0.032 |
| EI | 0.011 |
| Respiratory | 0.825 |
| NR-Aromatase | 0.894 |
| Antiviral | Yes |
| Prediction | 0.725972 |